Market Cap

Orthocell Limited Market Capitalization:

A$73.3 Million

AUD as of July 1, 2024

US$48.8 Million

business Orthocell Limited Company Profile

Orthocell Limited Main Stock Listing

ASX: OCC

Market Capitalization History of Orthocell Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Orthocell Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$82.7 M 1.05%
Jan. 1, 2023 A$81.8 M -5.81%
Jan. 1, 2022 A$86.9 M -18.10%
Jan. 31, 2021 A$106.1 M 8.25%
Jan. 1, 2021 A$98.0 M 61.67%
Jan. 31, 2020 A$60.6 M -37.50%
Jan. 1, 2020 A$97.0 M 269.23%
Jan. 31, 2019 A$26.3 M -7.14%
Jan. 1, 2019 A$28.3 M -54.84%
Jan. 31, 2018 A$62.6 M -11.43%
Jan. 1, 2018 A$70.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Orthocell Limited Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Orthocell Limited has the following listings and related stock indices.


Stock: ASX: OCC

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.